Smartleaf Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.18K | Buy |
106
+100
| +1,667% | +$3K | ﹤0.01% | 2192 |
|
|
2025
Q1 | $208 | Sell |
6
-175
| -97% | -$6.07K | ﹤0.01% | 2794 |
|
|
2024
Q4 | $9.17K | Buy |
181
+25
| +16% | +$1.27K | ﹤0.01% | 2025 |
|
|
2024
Q3 | $7.92K | Buy |
156
+24
| +18% | +$1.22K | ﹤0.01% | 1898 |
|
|
2024
Q2 | $5.74K | Buy |
+132
| New | +$5.74K | ﹤0.01% | 1731 |
|